DEXMOPET SOLUTION FOR INJECTION FOR DOGS AND CATS
DEXMOPET SOLUTION FOR INJECTION FOR DOGS AND CATS
Authorised
- Dexmedetomidine hydrochloride
Product identification
Medicine name:
DEXMOPET SOLUTION FOR INJECTION FOR DOGS AND CATS
Active substance:
- Dexmedetomidine hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Dexmedetomidine hydrochloride0.50/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM18
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetpharma Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Chemical Iberica Productos Veterinarios S.L.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V508462
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0290/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Denmark
-
Germany
-
Ireland
-
Norway
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
eu-puar-frv0290001-mr-rpe334-en.pdf
English (PDF)
Download Published on: 13/03/2026